Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Inventory (2016 - 2025)

Historic Inventory for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to -$221.5 million.

  • Fresenius Medical Care AG's Inventory fell 174847.92% to -$221.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$221.5 million, marking a year-over-year decrease of 174847.92%. This contributed to the annual value of $2.2 billion for FY2024, which is 574.55% down from last year.
  • Fresenius Medical Care AG's Inventory amounted to -$221.5 million in Q3 2025, which was down 174847.92% from $2.3 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Inventory ranged from a high of $2.3 billion in Q4 2023 and a low of -$221.5 million during Q3 2025
  • Its 5-year average for Inventory is $649.9 million, with a median of -$60.5 million in 2024.
  • Data for Fresenius Medical Care AG's Inventory shows a peak YoY increase of 501040.26% (in 2025) and a maximum YoY decrease of 174847.92% (in 2025) over the last 5 years.
  • Fresenius Medical Care AG's Inventory (Quarter) stood at $2.3 billion in 2021, then grew by 0.48% to $2.3 billion in 2022, then grew by 0.08% to $2.3 billion in 2023, then fell by 5.75% to $2.2 billion in 2024, then plummeted by 110.02% to -$221.5 million in 2025.
  • Its last three reported values are -$221.5 million in Q3 2025, $2.3 billion for Q2 2025, and $2.2 billion during Q1 2025.